{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:34:26Z","timestamp":1786995266285,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ogla.2022.08.002","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T23:56:24Z","timestamp":1660262184000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Incidence and Risk Factors for Secondary Glaucoma in Eyes with Uveal Melanoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Anni E.","family":"Stadigh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi M.","family":"Puska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tero T.","family":"Kivel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ogla.2022.08.002_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/ICU.0000000000000550","article-title":"Glaucoma secondary to intraocular tumors: mechanisms and management","volume":"30","author":"Camp","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ogla.2022.08.002_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/08820530500351744","article-title":"Glaucomas secondary to intraocular melanomas","volume":"21","author":"Wanner","year":"2006","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ogla.2022.08.002_bib3","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0161-6420(87)33537-7","article-title":"Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors","volume":"94","author":"Shields","year":"1987","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ogla.2022.08.002_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.survophthal.2008.10.002","article-title":"Eye cancer related glaucoma: current concepts","volume":"54","author":"Radcliffe","year":"2009","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ogla.2022.08.002_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/eye.2009.43","article-title":"Ocular complications following I-125 brachytherapy for choroidal melanoma","volume":"23","author":"Wen","year":"2009","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.ogla.2022.08.002_bib6","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.ophtha.2004.03.027","article-title":"Ocular complications after iodine brachytherapy for large uveal melanomas","volume":"111","author":"Puusaari","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ogla.2022.08.002_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IJG.0000000000001393","article-title":"Glaucoma after iodine-125 brachytherapy for uveal melanoma: incidence and risk factors","volume":"29","author":"Kim","year":"2020","journal-title":"J\u00a0Glaucoma"},{"issue":"8","key":"10.1016\/j.ogla.2022.08.002_bib8","doi-asserted-by":"crossref","first-page":"e734","DOI":"10.1111\/aos.13418","article-title":"Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy","volume":"95","author":"Siedlecki","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.ogla.2022.08.002_bib9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ajo.2015.08.034","article-title":"Secondary enucleations for uveal melanoma: a 7-year retrospective analysis","volume":"160","author":"Fabian","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ogla.2022.08.002_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0161-6420(92)31899-8","article-title":"Long-term results of iodine 125 irradiation of uveal melanoma","volume":"99","author":"Packer","year":"1992","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ogla.2022.08.002_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183833","article-title":"Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas","volume":"12","author":"Tarmann","year":"2017","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.ogla.2022.08.002_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5114\/jcb.2018.77955","article-title":"Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II","volume":"10","author":"Miguel","year":"2018","journal-title":"J\u00a0Contemp Brachytherapy"},{"issue":"8","key":"10.1016\/j.ogla.2022.08.002_bib13","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bjo.80.8.732","article-title":"Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma","volume":"80","author":"Summanen","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ogla.2022.08.002_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/sj.eye.6701361","article-title":"125I plaque brachytherapy for anterior uveal melanomas","volume":"18","author":"Lumbroso-Le Rouic","year":"2004","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.ogla.2022.08.002_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000495249","article-title":"Iodine-125 episcleral plaque brachytherapy for AJCC T4 posterior uveal melanoma: clinical outcomes in 158 Patients","volume":"5","author":"King","year":"2019","journal-title":"Ocul Oncol Pathol"},{"issue":"22","key":"10.1016\/j.ogla.2022.08.002_bib16","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","article-title":"Staging of ciliary body and choroidal melanomas based on anatomic extent","volume":"31","author":"Kujala","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ogla.2022.08.002_bib17","series-title":"AJCC Cancer Staging Manual","first-page":"805","article-title":"Chapter 67: Uveal melanoma","author":"Kivel\u00e4","year":"2017"},{"issue":"1","key":"10.1016\/j.ogla.2022.08.002_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/sim.4780040112","article-title":"A\u00a0Wilcoxon-type test for trend","volume":"4","author":"Cuzick","year":"1985","journal-title":"Stat Med"},{"key":"10.1016\/j.ogla.2022.08.002_bib19","series-title":"Handbook of Statistics in Clinical Oncology","first-page":"513","article-title":"Why Kaplan-Meier fails and cumulative incidence succeeds when estimating failure probabilities in the presence of competing risks","author":"Gooley","year":"2001"},{"key":"10.1016\/j.ogla.2022.08.002_bib20","series-title":"Modeling Survival Data: Extending the Cox Model","first-page":"127","article-title":"Testing proportional hazards","author":"Therneau","year":"2000"},{"key":"10.1016\/j.ogla.2022.08.002_bib21","doi-asserted-by":"crossref","unstructured":"Jouhi S, Al-Jamal RT, T\u00e4ll M, Eskelin S, Kivel\u00e4 TT. Presumed incipient choroidal melanoma: proposed diagnostic criteria and management. Br J Ophthalmol. 2021 Oct 19;bjophthalmol-2020-318658. doi: 10.1136\/bjophthalmol-2020-318658. Online ahead of print.","DOI":"10.1136\/bjophthalmol-2020-318658"},{"issue":"10","key":"10.1016\/j.ogla.2022.08.002_bib22","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(02)01181-8","article-title":"Plaque radiotherapy for large posterior uveal melanomas (> or\u00a0=8-mm thick) in 354 consecutive patients","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ogla.2022.08.002_bib23","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00417-017-3703-0","article-title":"Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy","volume":"255","author":"Hegde","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ogla.2022.08.002_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamaophthalmol.2014.111","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases","volume":"132","author":"Sagoo","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ogla.2022.08.002_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3129\/i09-097","article-title":"Management of ciliary body melanoma with iodine-125 plaque brachytherapy","volume":"44","author":"Krema","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ogla.2022.08.002_bib26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/archopht.117.2.170","article-title":"Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement","volume":"117","author":"G\u00fcnd\u00fcz","year":"1999","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ogla.2022.08.002_bib27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.brachy.2012.01.012","article-title":"Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma","volume":"12","author":"Marconi","year":"2013","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.ogla.2022.08.002_bib28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-9394(02)02241-9","article-title":"Custom-designed plaque radiotherapy for nonresectable iris melanoma in 38 patients: tumor control and ocular complications","volume":"135","author":"Shields","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ogla.2022.08.002_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajo.2009.08.007","article-title":"Management of iris melanomas with 125iodine plaque radiotherapy","volume":"149","author":"Fernandes","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ogla.2022.08.002_bib30","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/eye.2011.222","article-title":"Plaque radiotherapy treatment with ruthenium-106 for iris malignant melanoma","volume":"25","author":"Tsimpida","year":"2011","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ogla.2022.08.002_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/bjophthalmol-2017-310278","article-title":"Use of ruthenium-106 brachytherapy for iris melanoma: the Scottish experience","volume":"102","author":"Agraval","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ogla.2022.08.002_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1755-3768.2010.01967.x","article-title":"Ruthenium plaque radiation therapy for iris and iridociliary melanomas","volume":"90","author":"Razzaq","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ogla.2022.08.002_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/bjophthalmol-2017-310688","article-title":"Ruthenium-106 brachytherapy for iris and iridociliary melanomas","volume":"102","author":"Marinkovic","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ogla.2022.08.002_bib34","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0161-6420(03)00661-4","article-title":"Iodine brachytherapy as an alternative to enucleation for large uveal melanomas","volume":"110","author":"Puusaari","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2022.08.002_bib35","article-title":"Metastatic uveal melanoma: the final frontier","volume":"6","author":"Rantala","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ogla.2022.08.002_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0161-6420(00)00449-8","article-title":"Iris melanoma: risk factors for metastasis in 169 consecutive patients","volume":"108","author":"Shields","year":"2001","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ogla.2022.08.002_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archophthalmol.2011.286","article-title":"Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study","volume":"130","author":"Khan","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ogla.2022.08.002_bib38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ophtha.2017.11.040","article-title":"Iris melanoma outcomes based on the American Joint Committee on Cancer classification (eighth edition) in 432 patients","volume":"125","author":"Shields","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ogla.2022.08.002_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ophtha.2004.09.028","article-title":"Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma","volume":"112","author":"Detorakis","year":"2005","journal-title":"Ophthalmology"},{"issue":"S256","key":"10.1016\/j.ogla.2022.08.002_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2016.0125","article-title":"Indications and interpretation of various imaging techniques","volume":"94","author":"Zografos","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.ogla.2022.08.002_bib41","first-page":"2085","article-title":"Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance","volume":"42","author":"Kivel\u00e4","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ogla.2022.08.002_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.survophthal.2017.01.007","article-title":"Ring melanoma of the anterior chamber angle as a mimicker of pigmentary glaucoma","volume":"62","author":"Stadigh","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.ogla.2022.08.002_bib43","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/bjo.81.8.691","article-title":"Retinoinvasive malignant melanoma of the uvea","volume":"81","author":"Kivel\u00e4","year":"1997","journal-title":"Br J Ophthalmol"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419622001521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589419622001521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:53:19Z","timestamp":1762887199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589419622001521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2589419622001521"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2022.08.002","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Risk Factors for Secondary Glaucoma in Eyes with Uveal Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2022.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}